Prior SARS-CoV-2 in patients with CAR-T negatively impacts overall survival, highlighting the need for targeted prophylaxis strategies.
This poster was created for the National Comprehensive Cancer Network Conference. This ongoing study characterizes real-world outcomes including overall survival (rwOS) among patients who received CAR-T, by SARS-CoV-2 infection status prior to therapy.